Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A quick look at the safest stablecoins for newcomers, highlighting factors like reserve transparency and market liquidity.
19,229 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When a company's CFO sells stock, investors watch closely. This analysis dives into Commvault Systems' sold over trad...
The U.S. economy grew in the final months of last year, expanding at a 1.4% annual rate in Oct-Dec, but the pace slow...
A little-known semiconductor company just won EY’s World Entrepreneur of the Year in Monaco, signaling a new era of r...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
Uber is moving ride booking from the curb to the front desk, partnering with Mews to embed Uber rides directly into h...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
Regulators green-light a new type of BTC trading on Kalshi. Learn how the CFTC's approval of Bitcoin perpetual future...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
Realty ONE Group announces Zone Pro AI, a rebuilt platform that centralizes referrals, training, and workflows for mo...
A new private space station race is heating up, and Vast is stepping in with a bold plan. This could shift how invest...
AI stocks keep surprising investors with durable growth. Here’s a detailed, practical case for a single stock that ch...